Bahl & Gaynor Inc. Sells 8,627 Shares of Encompass Health Co. (NYSE:EHC)

Bahl & Gaynor Inc. decreased its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 27.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,001 shares of the company's stock after selling 8,627 shares during the period. Bahl & Gaynor Inc.'s holdings in Encompass Health were worth $2,124,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health during the third quarter worth $40,000. Tompkins Financial Corp acquired a new position in Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC boosted its holdings in Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Morse Asset Management Inc acquired a new position in Encompass Health during the third quarter worth $68,000. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

EHC stock traded down $0.47 during trading hours on Friday, reaching $99.20. The stock had a trading volume of 2,101,908 shares, compared to its average volume of 632,803. The stock has a market capitalization of $9.99 billion, a PE ratio of 22.24, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The stock has a 50-day simple moving average of $96.84 and a 200 day simple moving average of $96.61. Encompass Health Co. has a fifty-two week low of $74.27 and a fifty-two week high of $104.55.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is presently 15.25%.

Analyst Ratings Changes

Several research analysts recently commented on EHC shares. Royal Bank of Canada restated an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays increased their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. KeyCorp increased their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $107.67.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the firm's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.